Specialized pro-resolving mediator precursor (SPM precursor)

Pro-resolving lipid mediator precursor activity" is not a specific molecule or receptor but rather refers to the **precursor molecules**—primarily polyunsaturated fatty acids such as omega-3 and omega-6 fatty acids—that are metabolized by enzymes like lipoxygenases, cyclooxygenases, and cytochrome P450 monooxygenases to generate **specialized pro-resolving mediators** (SPMs)[1][2][3]. These SPMs include resolvins, protectins, maresins, and lipoxins. The precursors themselves do not act as therapeutic targets; instead, their enzymatic conversion products are bioactive agents that orchestrate the resolution phase of inflammation[1][2][4]. Therefore, "pro-resolving lipid mediator precursor activity" is a functional or biochemical process rather than a discrete molecular target suitable for drug development. The actual therapeutic targets in this pathway are either the enzymes responsible for converting precursors into SPMs or the receptors that mediate SPM actions[4]. Because this entry does not refer to a single defined protein or receptor but rather an activity/process involving multiple substrates and pathways upstream of known bioactive molecules (the SPMs), it should be flagged as incorrect if used as a canonical drug target name.

Other names

Pro-resolving lipid mediator precursorSPM precursorPrecursor of specialized pro-resolving mediators